Literature DB >> 11350843

Analysis of the cell infiltrate and expression of matrix metalloproteinases and granzyme B in paired synovial biopsy specimens from the cartilage-pannus junction in patients with RA.

T J Smeets1, M C Kraan, S Galjaard, P P Youssef, M D Smith, P P Tak.   

Abstract

OBJECTIVES: Examination of synovial tissue (ST) obtained at surgery because of end stage destructive rheumatoid arthritis (RA) showed that macrophages and fibroblasts are the major cell types at the cartilage-pannus junction (CPJ). This study aimed at defining the cell infiltrate and mediators of joint destruction in ST selected at arthroscopy from the CPJ in patients with RA who did not require joint surgery.
METHODS: Paired synovial biopsy specimens were obtained at arthroscopy from ST adjacent to the CPJ and the suprapatellar pouch from the knee joints of 17 patients with RA. Immunohistological analysis was performed using monoclonal antibodies to detect T cells, B cells, plasma cells, macrophages, fibroblast-like synoviocytes, mast cells, and granzyme B+ cytotoxic cells as well as the expression of metalloproteinase (MMP)-1, MMP-3, and MMP-13. The sections were evaluated by computer assisted image analysis and semiquantitative analysis.
RESULTS: The cell infiltrate comprised mainly T cells, macrophages, and plasma cells. The ST was also infiltrated by the other cell types, but at lower numbers. Expression of MMPs was abundant, especially MMP-3. The features of ST at the CPJ were generally similar to those at the suprapatellar pouch.
CONCLUSIONS: The synovium at the CPJ in patients with RA who did not require joint surgery exhibits, in general, the same type of cell infiltrate and expression of MMPs and granzymes as ST from the suprapatellar pouch. The pathological changes that have been described at the CPJ in patients with RA with end stage, destructive disease may well reflect the transition to a process in which macrophages, fibroblast-like synoviocytes, and other cell types become increasingly important.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11350843      PMCID: PMC1753677          DOI: 10.1136/ard.60.6.561

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  35 in total

Review 1.  Rheumatoid arthritis and p53: how oxidative stress might alter the course of inflammatory diseases.

Authors:  P P Tak; N J Zvaifler; D R Green; G S Firestein
Journal:  Immunol Today       Date:  2000-02

2.  Ultrastructure of synovio-cartilage junction in rheumatoid arthritis.

Authors:  H Tateishi
Journal:  Kobe J Med Sci       Date:  1973-06

3.  Histopathology of the rheumatoid lesion. Identification of cell types at sites of cartilage erosion.

Authors:  M Bromley; D E Woolley
Journal:  Arthritis Rheum       Date:  1984-08

4.  Polymorphonuclear granulocytes at the pannus-cartilage junction in rheumatoid arthritis.

Authors:  W Mohr; H Menninger
Journal:  Arthritis Rheum       Date:  1980-12

5.  Quantification of the cell infiltrate in synovial tissue by digital image analysis.

Authors:  M C Kraan; J J Haringman; M J Ahern; F C Breedveld; M D Smith; P P Tak
Journal:  Rheumatology (Oxford)       Date:  2000-01       Impact factor: 7.580

6.  Electron microscopic studies of the cartilage-pannus junction in rheumatoid arthritis.

Authors:  I Kobayashi; M Ziff
Journal:  Arthritis Rheum       Date:  1975 Sep-Oct

7.  Mast cells at sites of cartilage erosion in the rheumatoid joint.

Authors:  M Bromley; W D Fisher; D E Woolley
Journal:  Ann Rheum Dis       Date:  1984-02       Impact factor: 19.103

8.  Electron microscopic studies of the synovial-cartilage junction in rheumatoid arthritis.

Authors:  K D Muirden
Journal:  Eur J Rheumatol Inflamm       Date:  1982

9.  Morphologic observations in the early phase of the cartilage-pannus junction. Light and electron microscopic studies of active cellular pannus.

Authors:  S Shiozawa; K Shiozawa; T Fujita
Journal:  Arthritis Rheum       Date:  1983-04

10.  Collagenase at sites of cartilage erosion in the rheumatoid joint.

Authors:  D E Woolley; M J Crossley; J M Evanson
Journal:  Arthritis Rheum       Date:  1977 Jul-Aug
View more
  31 in total

Review 1.  A question of transformation: the synovial fibroblast in rheumatoid arthritis.

Authors:  Laurie S Davis
Journal:  Am J Pathol       Date:  2003-05       Impact factor: 4.307

2.  Radiation protection following nuclear power accidents: a survey of putative mechanisms involved in the radioprotective actions of taurine during and after radiation exposure.

Authors:  Olav Albert Christophersen
Journal:  Microb Ecol Health Dis       Date:  2012-02-01

Review 3.  Standardisation of synovial tissue infiltrate analysis: how far have we come? How much further do we need to go?

Authors:  M D Smith; D Baeten; A-K Ulfgren; I B McInnes; O Fitzgerald; B Bresnihan; P P Tak; D Veale
Journal:  Ann Rheum Dis       Date:  2005-06-23       Impact factor: 19.103

4.  Detailed analysis of the cell infiltrate and the expression of mediators of synovial inflammation and joint destruction in the synovium of patients with psoriatic arthritis: implications for treatment.

Authors:  A W R van Kuijk; P Reinders-Blankert; T J M Smeets; B A C Dijkmans; P P Tak
Journal:  Ann Rheum Dis       Date:  2006-05-25       Impact factor: 19.103

Review 5.  Progress in matrix metalloproteinase research.

Authors:  Gillian Murphy; Hideaki Nagase
Journal:  Mol Aspects Med       Date:  2008-05-24

6.  Acidosis induces synovial fibroblasts to release vascular endothelial growth factor via acid-sensitive ion channel 1a.

Authors:  Xuewen Qian; Yihao Zhang; Jingjing Tao; Ruowen Niu; Sujing Song; Cong Wang; Xiaoqing Peng; Feihu Chen
Journal:  Lab Invest       Date:  2020-08-21       Impact factor: 5.662

Review 7.  Synovial tissue research: a state-of-the-art review.

Authors:  Carl Orr; Elsa Vieira-Sousa; David L Boyle; Maya H Buch; Christopher D Buckley; Juan D Cañete; Anca I Catrina; Ernest H S Choy; Paul Emery; Ursula Fearon; Andrew Filer; Danielle Gerlag; Frances Humby; John D Isaacs; Søren A Just; Bernard R Lauwerys; Benoit Le Goff; Antonio Manzo; Trudy McGarry; Iain B McInnes; Aurélie Najm; Constantino Pitzalis; Arthur Pratt; Malcolm Smith; Paul P Tak; Rogier Thurlings; João E Fonseca; Douglas J Veale; Sander W Tas
Journal:  Nat Rev Rheumatol       Date:  2017-07-13       Impact factor: 20.543

8.  IRF5 controls both acute and chronic inflammation.

Authors:  Miriam Weiss; Adam J Byrne; Katrina Blazek; David G Saliba; James E Pease; Dany Perocheau; Marc Feldmann; Irina A Udalova
Journal:  Proc Natl Acad Sci U S A       Date:  2015-08-17       Impact factor: 11.205

9.  Active leflunomide metabolite inhibits interleukin 1beta, tumour necrosis factor alpha, nitric oxide, and metalloproteinase-3 production in activated human synovial tissue cultures.

Authors:  O Elkayam; I Yaron; I Shirazi; R Judovitch; D Caspi; M Yaron
Journal:  Ann Rheum Dis       Date:  2003-05       Impact factor: 19.103

10.  A prospective, randomised, placebo-controlled study to identify biomarkers associated with active treatment in psoriatic arthritis: effects of adalimumab treatment on synovial tissue.

Authors:  A W R van Kuijk; D M Gerlag; K Vos; G Wolbink; M de Groot; M A de Rie; A H Zwinderman; B A C Dijkmans; P P Tak
Journal:  Ann Rheum Dis       Date:  2008-07-22       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.